Highlights and Quick Summary
- Consolidated Net Income/Loss for the quarter ending December 31, 2022 was $-22.2 Million (a -125.38% decrease compared to previous quarter)
- Year-over-year quarterly Consolidated Net Income/Loss increased by 15.19%
- Annual Consolidated Net Income/Loss for 2022 was $28.3 Million (a -130.72% decrease from previous year)
- Annual Consolidated Net Income/Loss for 2021 was $-92.2 Million (a -45.95% decrease from previous year)
- Annual Consolidated Net Income/Loss for 2020 was $-171 Million (a -47.36% decrease from previous year)
- Twelve month Consolidated Net Income/Loss ending December 31, 2022 was $-75.1 Million (a -3.66% decrease compared to previous quarter)
- Twelve month trailing Consolidated Net Income/Loss decreased by -20.16% year-over-year
Trailing Consolidated Net Income/Loss for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| $-75.1 Million | $-78 Million | $-100 Million | $-94.1 Million |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Consolidated Net Income/Loss of Precigen, Inc.
Most recent Consolidated Net Income/Lossof PGEN including historical data for past 10 years.Interactive Chart of Consolidated Net Income/Loss of Precigen, Inc.
Precigen, Inc. Consolidated Net Income/Loss for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $-22.18 | $87.38 | $-17.64 | $-19.25 | $28.32 |
| 2021 | $-25.03 | $-29.76 | $-20.05 | $-17.32 | $-92.17 |
| 2020 | $-41.66 | $-29.51 | $-43.35 | $-56.0 | $-170.52 |
| 2019 | $-169.22 | $-53.63 | $-38.93 | $-62.14 | $-323.92 |
| 2018 | $-341.72 | $-58.75 | $-66.83 | $-47.41 | $-514.71 |
| 2017 | $-33.95 | $-40.84 | $-19.66 | $-32.38 | $-126.82 |
| 2016 | $-44.91 | $-30.01 | $-50.03 | $-65.32 | $-190.27 |
| 2015 | $-33.28 | $-39.03 | $-41.49 | $25.8 | $-87.99 |
| 2014 | $17.93 | $-53.86 | $-52.94 | $3.25 | $-85.62 |
| 2013 | $-13.02 | $14.99 | $-6.52 | $-36.36 | $-40.91 |
| 2012 | $-20.49 | $-16.54 | – | – | $-81.87 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology